Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

biote Corp. (BTMD)

4.1057   0.136 (3.42%) 11-25 11:19
Open: 4.09 Pre. Close: 3.97
High: 4.12 Low: 3.9875
Volume: 1,148 Market Cap: 31(M)

Technical analysis

as of: 2022-11-25 1:55:43 PM
Overall:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 5.36     One year: 6.26
Support: Support1: 3.97    Support2: 3.59
Resistance: Resistance1: 4.59    Resistance2: 5.36
Pivot: 3.97
Moving Average: MA(5): 3.93     MA(20): 4.06
MA(100): 4.19     MA(250): 6.96
MACD: MACD(12,26): -0.1     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 51.3     %D(3): 39.5
RSI: RSI(14): 50.4
52-week: High: 10.52  Low: 2
Average Vol(K): 3-Month: 34 (K)  10-Days: 10 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BTMD ] has closed below upper band by 24.4%. Bollinger Bands are 45.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.13 - 4.15 4.15 - 4.17
Low: 3.74 - 3.76 3.76 - 3.78
Close: 4.1 - 4.13 4.13 - 4.16

Company Description

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Headline News

Thu, 10 Nov 2022
Biote to Present at Jefferies London Healthcare Conference - Biote (NASDAQ:BTMD) - Benzinga

Tue, 08 Nov 2022
Biote Reports Third Quarter Financial Results - Business Wire

Mon, 07 Nov 2022
Biote Appoints Debby Morris to Board of Directors - Yahoo Finance

Mon, 31 Oct 2022
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call - Yahoo Finance

Tue, 27 Sep 2022
Truist Financial has initiated coverage of biote (NASDAQ:BTMD). - Best Stocks

Tue, 20 Sep 2022
Pre-market Movers: PGY, BCAN, BTMD, MGAM, HKD… - RTTNews

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  PNK
Sector:  Healthcare
Industry:  Medical Care Facilities
Shares Out. 8 (M)
Shares Float 6 (M)
% Held by Insiders 72.2 (%)
% Held by Institutions 22.6 (%)
Shares Short 36 (K)
Shares Short P.Month 123 (K)

Stock Financials

EPS 17.09
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.65
Profit Margin (%) 68.1
Operating Margin (%) -39.3
Return on Assets (ttm) -49.3
Return on Equity (ttm) 0
Qtrly Rev. Growth 18
Gross Profit (p.s.) 11.96
Sales Per Share 20.87
EBITDA (p.s.) -8.07
Qtrly Earnings Growth 0
Operating Cash Flow -5 (M)
Levered Free Cash Flow 40 (M)

Stock Valuations

PE Ratio 0.24
PEG Ratio 0
Price to Book value -6.32
Price to Sales 0.19
Price to Cash Flow -6.06

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.